Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.
Level 5 - mechanism / opinion, no new human data
Narrative review of preclinical and animal research with mechanism-based reasoning
PubMed 34267654 · doi:10.3389/fphar.2021.627533
What was done
This paper is a narrative review summarizing the actions of the stable gastric pentadecapeptide BPC 157 in wound healing models, including incisional and excisional wounds, deep burns, diabetic ulcers, alkali burns, and various internal fistulas in rats.
What was found
No quantitative numbers, effect sizes, or statistical metrics are reported in the abstract. Qualitatively, BPC 157 is reported to heal cutaneous and fistular wounds in rats, resolve vessel constriction and platelet/fibrin clots, prevent arterial and venous thrombosis, bypass vascular occlusions during ischemia/reperfusion, and upregulate gene expression in rat excision skin wounds.
Why it matters
The review summarizes experimental rationales for using BPC 157 as a multi-tissue regenerative and vascular-modulating peptide in wound care.
Limits
The findings described in the abstract derive almost entirely from rat models rather than human clinical trials. No quantitative outcomes, sample sizes, or systematic review search methodologies are provided in the abstract.
Cited by
- supports BPC-157 aids in tissue recovery and gut health.